Insider Buying: American Healthcare REIT, Inc. (NYSE:AHR) CEO Acquires $355,000.00 in Stock

American Healthcare REIT, Inc. (NYSE:AHR) CEO Danny Prosky bought 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was purchased at an average cost of $14.20 per share, for a total transaction of $355,000.00. Following the completion of the purchase, the chief executive officer now owns 108,333 shares of the company’s stock, valued at $1,538,328.60. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

American Healthcare REIT Stock Performance

Shares of AHR stock opened at $14.00 on Monday. American Healthcare REIT, Inc. has a 12 month low of $12.63 and a 12 month high of $14.90. The company has a current ratio of 0.33, a quick ratio of 0.33 and a debt-to-equity ratio of 0.60. The firm’s fifty day simple moving average is $13.90.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 19th. Stockholders of record on Thursday, March 28th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.14%. The ex-dividend date of this dividend was Wednesday, March 27th.

Analyst Ratings Changes

A number of brokerages have issued reports on AHR. Barclays began coverage on shares of American Healthcare REIT in a research report on Thursday, March 14th. They set an “overweight” rating and a $18.00 price objective on the stock. Royal Bank of Canada began coverage on shares of American Healthcare REIT in a research report on Monday, March 4th. They set an “outperform” rating and a $15.00 price objective on the stock. JMP Securities reissued a “market outperform” rating and set a $16.00 price objective on shares of American Healthcare REIT in a research report on Thursday, May 16th. Truist Financial reduced their price objective on shares of American Healthcare REIT from $17.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Finally, Bank of America began coverage on shares of American Healthcare REIT in a research report on Monday, March 4th. They set a “buy” rating and a $15.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT currently has a consensus rating of “Moderate Buy” and an average target price of $15.88.

Institutional Trading of American Healthcare REIT

A number of hedge funds have recently modified their holdings of the business. Virtu Financial LLC bought a new stake in shares of American Healthcare REIT during the 1st quarter valued at $308,000. Zimmer Partners LP bought a new position in American Healthcare REIT in the 1st quarter worth about $6,269,000. Kodai Capital Management LP bought a new position in American Healthcare REIT in the 1st quarter worth about $336,000. V3 Capital Management L.P. bought a new position in American Healthcare REIT in the 1st quarter worth about $42,337,000. Finally, Quadrature Capital Ltd bought a new position in American Healthcare REIT in the 1st quarter worth about $914,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.